Hepatitis B and C infection in patients undergoing biologic and targeted therapies for rheumatic diseases

This article summarizes the prevalence and risk factors of hepatitis B and C reactivation in patients with rheumatic diseases undergoing biologic and targeted therapies, as well as the recommendations for screening, monitoring, and treatment of these infections.
Source: Best Practice and Research Clinical Rheumatology - Category: Rheumatology Source Type: research